Insider trades
Jason Haas, Director of Ligand Pharmaceuticals LGND, has filed 4 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $1.6M. The latest trade was on 06/12.
Jason Haas
Director
- Company
- Ligand Pharmaceuticals LGND
- First filing
- 23/02/21
- Trades
- 34 trades
- Buys / sales
- 4 / 3
- 12-month net buying
- −$1.6M
- Last trade
- 06/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
LGND | Open-market sale | 06/12 | 06/15 | 6,461 sh2 trades | $255.58avg. | $1,651,322.88 | −56.5% |
| Open-market buy | 05/08 | 05/11 | 1,000 sh | $20.00 | $20,000 | +1.6% | |
| Open-market sale | 24/11/18 | 24/11/20 | 137,803 sh | $0.21 | $28,938.63 | −100.0% | |
| Open-market buy | 24/09/10–24/09/12 | 24/09/12 | 100,000 sh3 trades | $1.61avg. | $161,473.51 | +407.3% |
